Navigation Links
Paradigm is Successful at Annual Vision Source Meeting in Houston, Texas
Date:4/27/2011

SALT LAKE CITY, April 27, 2011 /PRNewswire/ -- Paradigm Medical Industries, Inc. (OTC: PDMI.PK) announced its success at the annual meeting of Vision Source, an optometric organization, which was held at the Houston Convention Center in Houston, Texas from April 14-17, 2011.  Over 2,300 private practice optometrists from many of the most highly regarded practices in the United States were in attendance at the annual meeting.  The meeting provided opportunities for participating optometrists to attend practice building seminars, benefit from shared peer experience, and purchase equipment from vendors approved by Vision Source.

"This important annual meeting with Vision Source's members resulted in creating many new sales opportunities for Paradigm's products, including the Blood Flow Analyzer™, the P60 UBM Ultrasound Biomicroscope, the new LD 500 autoperimeter, and the new Paramax™.  New sales were made and numerous quality leads that will lead to future sales made the meeting a great success," said Stephen L. Davis, Paradigm's President and Chief Executive Officer.

Mr. Davis added, "The opportunity to attend the meeting filled an important sales objective for Paradigm to reestablish its working relationship with the Vision Source group and introduce Paradigm's high technology diagnostic eye care instruments for early detection of glaucoma and other eye disorders to this important professional eye care group."

Vision Source is an invitation only, private optometric organization that requires its members to pay an annual membership fee to belong and benefit from its membership.  Members learn new practice building skills, improve staff development, and gain valuable general business tips.  Members also enjoy reduced pricing from approved vendors who financially support these efforts.  

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Contact: Stephen L. Davis
President and Chief Executive Officer
801-977-8970
www.paradigm-medical.com


'/>"/>
SOURCE Paradigm Medical Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
2. Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
3. Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies
4. Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections
5. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
6. Reportlinker Adds Successful Strategies for Drug Repositioning
7. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
8. Creating a Road Map for Successful Metabolic New Product Launches
9. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
10. Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
11. Successful Strategies and Innovative Practices for Bringing FDC Products to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... while the Dow Jones Industrial Average managed to stay in ... markets, which prompted Stock-callers this morning to look at the ... NUVA ), Smith & Nephew PLC (NYSE: ... and Cesca Therapeutics Inc. (NASDAQ: KOOL ). You ...
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... provided additional information on its previously announced Accelerated Share Repurchase ... ... As previously announced, the Company entered ... under which the Company will repurchase $10 billion of its ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... Palm Beach Gardens, FL (PRWEB) , ... November ... ... leader in eating disorder and mental health treatment has announced the opening of ... facility provides specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, ...
(Date:11/30/2016)... ... November 30, 2016 , ... In ... been a focus of public policymakers and system stakeholders in many states. To ... its Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , ...
(Date:11/30/2016)... ... 2016 , ... The Clinical Data Interchange Standards Consortium (CDISC) ... goes into effect next month. Sponsors whose studies start after December 17, 2016 ... The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):